Lupitidine
Overview[edit]
Lupitidine is a histamine H2 receptor antagonist used in the treatment of peptic ulcer disease and gastroesophageal reflux disease (GERD). It works by reducing the amount of stomach acid produced by the parietal cells in the stomach.
Mechanism of Action[edit]
Lupitidine functions by blocking the H2 receptors on the parietal cells of the stomach lining. This inhibition prevents histamine from binding to these receptors, which in turn reduces the secretion of gastric acid. By decreasing acid production, lupitidine helps in alleviating symptoms associated with excessive acid, such as heartburn and indigestion.
Clinical Uses[edit]
Lupitidine is primarily indicated for:
- Peptic ulcer disease
- Gastroesophageal reflux disease (GERD)
- Zollinger-Ellison syndrome
- Prevention of stress ulcers in critically ill patients
Side Effects[edit]
Common side effects of lupitidine may include:
Rare but serious side effects can include:
Pharmacokinetics[edit]
Lupitidine is absorbed rapidly from the gastrointestinal tract and undergoes first-pass metabolism in the liver. It is excreted primarily through the kidneys. The half-life of lupitidine is approximately 2-3 hours, which may be prolonged in patients with renal impairment.
Administration[edit]
Lupitidine is available in oral tablet form and is typically administered once or twice daily, depending on the condition being treated. Dosage adjustments may be necessary for patients with renal insufficiency.
